Daniel Trencher - 30 Aug 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF STRATEGY OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
30 Aug 2024
Net transactions value
-$12,730
Form type
4
Filing time
04 Sep 2024, 16:12:01 UTC
Previous filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +951 +3.4% 29,273 30 Aug 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,179 +4% 30,452 30 Aug 2024 Direct F2
transaction TDOC Common Stock Options Exercise +2,790 +9.2% 33,242 30 Aug 2024 Direct F2
transaction TDOC Common Stock Sale $12,730 -1,777 -5.3% $7.16 31,465 03 Sep 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -951 -14% $0.000000 5,706 30 Aug 2024 Common Stock 951 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1,179 -33% $0.000000 2,359 30 Aug 2024 Common Stock 1,179 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -2,790 -14% $0.000000 16,742 30 Aug 2024 Common Stock 2,790 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.